1,3,5,7-Undecatetraene, (Z,Z,E)-
| Common Name: |
1,3,5,7-Undecatetraene, (Z,Z,E)- |
| IUPAC Name: |
undeca-1,3,5,7-tetraene |
| Molecular Formula: |
C11H16 |
| SMILES: |
CCCC=CC=CC=CC=C |
| Inchi: |
1S/C11H16/c1-3-5-7-9-11-10-8-6-4-2/h3,5,7-11H,1,4,6H2,2H3 |
| Inchi Key: |
IQQBFWHNQBNSSQ-UHFFFAOYSA-N |
| Cas No: |
116963-97-4 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
1 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
2 |
| Name |
Value |
| Molecular Weight (g/mol) |
148.24 |
| Mass (g/mol) |
148.125 |
| Molar Refractivity |
53.09 |
| Net Charge |
|
| HBD |
|
| HBA |
0 |
| Rt Bonds |
5 |
| Rings |
|
| TPSA |
0.00 |
| Hetero Atoms |
0 |
| Heavy Atoms |
11 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
217.40 |
| Vapor Pressure (mmHg@25.00 °C) |
0.2 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.27 |
| LogP |
3.641 |
| iLOGP |
3.20 |
| XLOGP3 |
4.34 |
| WLOGP |
3.64 |
| MLOGP |
3.76 |
| ESOL Log S |
-3.16 |
| ESOL Solubility (mg/ml) |
0.102 |
| ESOL Solubility (mol/l) |
0.001 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-4.05 |
| Ali Solubility (mg/ml) |
0.01 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Moderately soluble |
| Silicos-IT LogSw |
-1.77 |
| Silicos-IT Solubility (mg/ml) |
2.51 |
| Silicos-IT Solubility (mol/l) |
0.02 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
Low |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-4.12 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.55 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.59 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Warning |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
